Arabic Arabic English English French French German German

Second Genome Announces Milestone Accomplished in Collaboration with Bayer, Demonstrating Broad Application of Company’s Machine Learning Platform to Identify Novel Proteins for the Development of Next-Generation Insect-Control Solutions

Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision therapies and biomarkers from public and proprietary microbiome data, announced it has achieved a milestone in its multi-year collaboration with Bayer to discover proteins for potential development of next-generation insect-control products. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member

Next Post

LUNGevity Foundation and Partner Hamoui Family Foundation Issue 2022 Request for Applications for RET-Positive Clinical Lung Cancer Research

Related Posts